Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.
December’s Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter
| February Rank | January Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 29,401 | 2,784 | 150 |
| 2 | 2 | AstraZeneca | 17,319 | 1,314 | 23 |
| 3 | 3 | Johnson & Johnson | 7,918 | 1,232 | 142 |
| 4 | 5 | GSK | 714 | 254 | 52 |
| 5 | 4 | Sanofi | 643 | 272 | 94 |
| 6 | 7 | Merck & Co | 605 | 403 | 79 |
| 7 | 11 | Roche | 468 | 184 | 85 |
| 8 | 10 | Novartis | 433 | 304 | 51 |
| 9 | 9 | Bayer | 418 | 174 | 17 |
| 10 | 32 | Abbott | 382 | 2 | 0 |
| 11 | 14 | Mylan | 381 | 345 | 24 |
| 12 | 16 | Novo Nordisk | 293 | 240 | 24 |
| 13 | 8 | Lilly | 280 | 165 | 25 |
| 14 | 12 | Gilead | 268 | 154 | 32 |
| 15 | 13 | AbbVie | 169 | 138 | 11 |
| 16 | 23 | Otsuka | 162 | 10 | 2 |
| 17 | 15 | Amgen | 155 | 120 | 31 |
| 18 | 18 | BMS | 154 | 126 | 19 |
| 19 | 6 | Regeneron | 151 | 32 | 4 |
| 20 | 17 | Takeda | 119 | 101 | 23 |
| 21 | 21 | UCB | 111 | 108 | 67 |
| 22 | 28 | Fresenius | 109 | 71 | 21 |
| 23 | 20 | Boehringer | 101 | 84 | 27 |
| 24 | 26 | Merck KGaA | 74 | 64 | 8 |
| 25 | 19 | Biogen | 67 | 19 | 1 |
| 26 | 25 | Teva | 63 | 56 | 38 |
| 27 | 33 | Menarini | 45 | 39 | 26 |
| 28 | 35 | Astellas | 44 | 34 | 16 |
| 29 | 24 | Chugai | 43 | 0 | 0 |
| 30 | 31 | Ipsen | 38 | 34 | 16 |
| 31 | 38 | CSL | 32 | 32 | 21 |
| 32 | 22 | Grifols | 32 | 0 | 0 |
| 33 | 30 | Daiichi Sankyo | 29 | 12 | 5 |
| 34 | 34 | Servier | 29 | 15 | 0 |
| 35 | 36 | Vertex | 27 | 27 | 0 |
| 36 | 37 | Bausch | 24 | 2 | 1 |
| 37 | 27 | Eisai | 24 | 5 | 3 |
| 38 | 40 | Alexion | 23 | 21 | 1 |
| 39 | 29 | Allergan | 22 | 2 | 0 |
| 40 | 39 | Sun | 4 | 2 | 0 |
| 41 | 50 | Aurobindo | 1 | 0 | 0 |
| 50 | 50 | Endo | 0 | 0 | 0 |
| 50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
| 50 | 50 | Meiji | 0 | 0 | 0 |
| 50 | 50 | Mitsubishi Tanabe Pharma | 0 | 0 | 0 |
| 50 | 50 | Ono | 0 | 0 | 0 |
| 50 | 50 | Shanghai | 0 | 0 | 0 |
| 50 | 50 | Sino | 0 | 0 | 0 |
| 50 | 50 | Sumitomo Dainippon | 0 | 0 | 0 |
| 50 | 50 | Yunnan Baiyao | 0 | 0 | 0 |
December’s insights from HCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during December 2020 largely remained the same as last month: Pfizer, AstraZeneca, Johnson and Johnson (J&J), GSK and Sanofi.
December saw two vaccine approvals in the UK (Pfizer and AstraZeneca), sparking conversation globally. The volume of posts from HCPs about top 50 pharma companies increased by 75% from November to 72,790 throughout the month of December. There were also twice as many posts about Pfizer, just shy of 60,000.
The UK just approved the Pfizer Covid19 vaccine for widespread use. Vaccinations may start next week.
It is proven safe and 95% effective.
This makes UK the first country in the world to have a clinically approved Covid19 vaccine ready for widespread supply and immediate use.
— #OurFavOnlineDoc 🩺 🇬🇧 (@DrOlufunmilayo) December 2, 2020
The most shared links by HCPs covered key information around the two first-to-market vaccines in the UK:
- The FDA briefing document on Pfizer/BioNTech’s vaccine was shared the most by HCPs: 680 times.
- Relating to Oxford/AstraZeneca’s vaccine, HCPs shared a UK government press release upon the vaccine’s authorisation.
- Before this approval, HCPs shared an article from The Times writing that hospitals were near breaking point.
As AstraZeneca’s vaccine came closer to UK approval, HCPs used data to compare the vaccine candidates, with many explaining that the options were on par with each other.
BREAKING—95%—new data from Oxford/AstraZeneca vaccine shows 95% efficacy & is “100% effective” in preventing severe 🏥illness, says AZ CEO. That’s on par w/ Moderna & Pfizer. No official data yet, but UK 🇬🇧 said to likely approve in days. HUGE🧵. #COVID19
https://t.co/e4ra7GgmxG pic.twitter.com/YYn0MsORcy— Eric Feigl-Ding (@DrEricDing) December 27, 2020
COVID-19 conversation increased again since last month by 98%, making up a huge 84% of the overall conversation about top 50 pharmaceutical companies.
Beyond the COVID-19 conversation, HCPs continued engaging with each other in a way we have been tracking long before the digital transformation seen through the pandemic. One example is with Twitter Chats used for education which can be supported by pharmaceutical companies, such as #MondayNightIBD.
Would love to hear what interventions people use to help with transition from pediatric to adult care – does anything help? #MondayNightIBD
— Eric Benchimol (@ericbenchimol) December 14, 2020
CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
- In November 2020, CREATION Pinpoint® identified 72,790 healthcare professional (HCP) authored tweets from 25,238 individual HCPs mentioning a top-50 pharmaceutical company (according to revenue).
- Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 pharmaceutical company between December 1st and December 31st 2020.
- Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
- In some cases, a tweet may mention more than one company account (eg. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary Janssen. In December, 1,179 of the posts mentioned Janssen.
